Home » Drug Information » FDA-Approved Drugs » 1998
Medical Areas: Oncology
View By: Year Company Therapeutic Areas Drug Names
Drug Information
The following information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: QLT
Approval Status: Approved January 1998
Treatment Area: Non-small cell lung cancer
QLT PhotoTherapeutics' light-activated drug Photofrin
(porfimer sodium) was approved for injection in treating
early-stage, microinvasive lung cancer. It is approved for use in
patients with microinvasive endobronchial non-small cell lung
cancer at an early stage, for whom surgery and radiotherapy are not
indicated.
